Description

Reamberin (meglumine sodium succinate) solution for infusions 400 ml. vial

Ingredients

Reamberin solution for infusions contains meglumine sodium succinate as the active ingredient.

Dosage

The recommended dosage of Reamberin solution for infusions is determined by the healthcare provider based on the patient’s condition and needs.

Indications

Reamberin solution for infusions is indicated for use in conditions where metabolic disorders and acid-base balance disturbances are present.

Contraindications

Do not use Reamberin solution for infusions in patients with known hypersensitivity to any of the ingredients.

Directions

Reamberin solution for infusions should be administered intravenously as directed by a healthcare professional.

Scientific Evidence

Studies have shown that meglumine sodium succinate in Reamberin solution for infusions can help in the correction of metabolic acidosis and improve cellular metabolism.

Additional Information

It is important to monitor electrolyte levels and renal function during treatment with Reamberin solution for infusions.

Pharmacological Effects: Reamberin acts as a metabolic corrector by improving cellular energy metabolism and reducing oxidative stress. It helps in restoring the acid-base balance in the body, especially in conditions of metabolic acidosis.

Clinical Trials: Clinical trials have demonstrated the efficacy of Reamberin in improving the outcomes of patients with metabolic disorders. A study by Kirov et al. (2018) showed a significant improvement in organ function and survival rates in critically ill patients treated with Reamberin.